Clinical Trials

20 enrolled

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT06961669 2025-05-29

ECAR01

LymphoidOther hematologic neoplasmPlasma cell

18 enrolled

Multiple Myeloma, Recurrence, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05045040 2025-03-30

Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions

Phase NA Completed

264 enrolled

Communication, Neoplasms, Recurrence

NCT06363591 2025-03-05

WoW

LymphoidOther hematologic neoplasm

2,486 enrolled

Dermatologic

Death, Melanoma, Neoplasm Metastasis, Recurrence

NCT06670911 2025-02-24

ACCESS-I

Phase 2 Recruiting

44 enrolled

Recurrence

NCT01675219 2023-04-13

Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)

Phase 3 Unknown

400 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT05648019 2023-03-09

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Phase 2 Recruiting

40 enrolled

Burkitt Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05704231 2023-01-30

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Phase NA Unknown

60 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence, Smoking, Disease Progression

NCT03789513 2022-02-16

AIMA-CC

Phase NA Unknown

3,000 enrolled

LymphoidOther hematologic neoplasm

Uterine Cervical Neoplasms, Recurrence, HIV Infections, Papillomavirus Infections

NCT05137860 2022-01-18

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

Phase 4 Unknown

56 enrolled

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

886 enrolled

Gastrointestinal

Recurrence, Stomach Neoplasms

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

Phase 3 Unknown

356 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

20 enrolled

Other hematologic neoplasm

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT00342316 2020-01-27

Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

Phase NA Completed

340 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT02747732 2019-04-23

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

72 enrolled

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03881761 2019-03-21

CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma

Phase 1 Unknown

50 enrolled

LymphoidOther hematologic neoplasm

Recurrence, Lymphoma, B-Cell

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Phase 1 Unknown

20 enrolled

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03601624 2018-11-14

MM-POM-2018

18 enrolled

Plasma cell

Multiple Myeloma, Recurrence, Disease Progression

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

67 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT03540303 2018-05-30

Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma

Phase 1 Unknown

15 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Phase 4 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic

NCT02083211 2015-04-14

Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Phase 3 Completed

168 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

35 enrolled

Sarcoma

Recurrence, Sarcoma

NCT01086488 2011-07-08

FOSCAN

66 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT01300156 2011-02-21

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

37 enrolled